Summit Securities Group’s ICU Medical ICUI Stock Holding History

Summit Securities Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-300	Closed	-$32K	–	664
2024 Q1	$32K	Buy	+300	New	+$29.8K	0.01%	283

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit Securities Group's ICUI Position: Q2 2024 in Review

Summit Securities Group sold out of ICU Medical (ICUI) in Q2 2024, closing a stake of 300 shares — an estimated $32K sold.

Summit Securities Group first reported a position in ICUI in Q1 2024 and held it in 1 quarter. The position peaked at $32K in Q1 2024. 255 funds tracked by Wall St. Rank hold ICUI as of Q2 2024.

Summit Securities Group reported no remaining ICU Medical position as of Q2 2024 after selling out during the quarter.
Summit Securities Group sold 300 ICU Medical shares in Q2 2024, an estimated $32K.
Summit Securities Group first reported a position in ICU Medical in Q1 2024 and held it in 1 quarter.
Summit Securities Group's ICU Medical position peaked at $32K in Q1 2024.
255 funds tracked by Wall St. Rank held ICU Medical as of Q2 2024.

Based on Summit Securities Group's 13F filing for Q2 2024, filed 26 Jul 2024.